Smoking Cessation and Nicotine De-Addiction Products Market By Product (Nicotine Replacement Therapy Products, Drug Therapy, E-cigarettes), By Form (Gum, Inhaler, Tablet, Others), By Distribution Channel (Hospital Pharmacies, Online Provider, Drug stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global smoking cessation and nicotine de-addiction products market was valued at $19,965.28million in 2021, and is estimated to reach $54,708.87 million by 2031, growing at a CAGR of 10.6% from 2022 to 2031.
Smoking cessation or nicotine de-addiction means the act of stopping tobacco use. Tobacco contains alkaloid compound called nicotine, which causes addiction toward cigarettes and other smoking products. The addiction is caused by releasing neurotransmitters such as glutamate, dopamine, and gamma-aminobutyric acid (GABA). Furthermore, cigarette and tobacco addicts can be better treated with smoking cessation products.
Major factors that drive growth of the smoking cessation and nicotine de-addiction products market is the rise in number of populations who are quitting smoking and ant-smoking initiatives and campaigns by various governments and private organizations . Furthermore, shift of adults toward e-cigarettes also serves as a growing factor for the market. The Centers for Disease Control and Prevention (CDC) stated that, 60.2% of youth who used tobacco products have stopped using all these products for one day or longer as they were willing to quit tobacco in 2021.
The World Health Organization (WHO) launched a year-long global campaign for World No Tobacco Day 2021, “Commit to Quit challenge and published more than 100 reasons to quit tobacco to mark start of the campaign. In addition, free initiatives by governments, increase in consciousness and education among young population and smokers, and approved smoking cessation drugs in the market are leveraging smoking cessation and nicotine de-addiction products market. However, high cost of therapies can lead to decrease in purchase of these products, which can ultimately hinder growth of the market.
Key market players are investing in research and development of innovative solutions and therapies for smoking cessation. One such innovation is e-cigarettes. Normal cigarettes consist 90% tobacco, which is increasing demand of e-cigarette that is a battery-powered device that generates an inhaled aerosol and have very less tobacco.
According to the Centers for Disease Control and Prevention (CDC), cigarette smoking also causes various chronic disease such as lung cancer and chronic obstructive pulmonary disease (COPD). As smoke consists of over 7000 chemicals, with over 70 chemicals known to cause cancer in humans, rise in number of chronic ailments propel major companies to introduce innovative nicotine replacement therapy products further driving demand for nicotine replacement therapy products.
The global smoking cessation and nicotine de-addiction products market is segmented on the basis of product, form, distribution channel, and region. On the basis of product, the market is categorized into nicotine replacement therapy products, drug therapy, and e-cigarettes. The nicotine replacement therapy segment is further divided into nicotine lozenges, nicotine gums, nicotine sprays, and nicotine inhalers. By form, the market is divided into gum, inhalers, tablets, and others. By distribution channel, it is segmented into hospital pharmacies, online providers, and drug stores and retail pharmacies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
Major players profiled in the report are British American Tobacco Inc., 22nd Century group Inc., Cipla Ltd., Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline PLC (Haleon), Imperial Brands Plc. (Fontem Ventures), Johnson and Johnson (McNeil Consumer Health), Njoy Company, Pfizer Inc., Perrigo Company Plc., Rusan Pharma, and Zydus Cadila.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the smoking cessation and nicotine de-addiction products market analysis from 2021 to 2031 to identify the prevailing smoking cessation and nicotine de-addiction products market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the smoking cessation and nicotine de-addiction products market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global smoking cessation and nicotine de-addiction products market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Nicotine Replacement Therapy Products
Type
Nicotine Lozenges
Nicotine Gums
Nicotine Sprays
Nicotine Inhalers
Drug Therapy
E-cigarettes
By Form
Gum
Inhaler
Tablet
Others
By Distribution Channel
Hospital Pharmacies
Online Provider
Drug stores and Retail Pharmacies
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest Of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest Of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest Of LAMEA
Key Market Players
British American Tobacco Plc
22nd Century group Inc.
Cipla Ltd.
Dr. Reddy’s Laboratories Ltd.
GlaxoSmithKline Plc.
Imperial Brands Plc.
Johnson and Johnson Inc
Njoy Company
Perrigo Company Plc.
Pfizer Inc.
Zydus Cadila, Inc.
Rusan Pharma Ltd
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Nicotine Replacement Therapy Products
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
- 4.2.4.1 Nicotine Lozenges Market size and forecast, by region
- 4.2.4.2 Nicotine Gums Market size and forecast, by region
- 4.2.4.3 Nicotine Sprays Market size and forecast, by region
- 4.2.4.4 Nicotine Inhalers Market size and forecast, by region
- 4.3 Drug Therapy
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 E-cigarettes
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- CHAPTER 5: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Gum
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Inhaler
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Tablet
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Others
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- CHAPTER 6: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospital Pharmacies
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Online Provider
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Drug stores and Retail Pharmacies
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.2.1 North America Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
- 7.2.3 North America Market size and forecast, by Form
- 7.2.4 North America Market size and forecast, by Distribution Channel
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product
- 7.2.5.1.2 Market size and forecast, by Form
- 7.2.5.1.3 Market size and forecast, by Distribution Channel
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product
- 7.2.5.2.2 Market size and forecast, by Form
- 7.2.5.2.3 Market size and forecast, by Distribution Channel
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product
- 7.2.5.3.2 Market size and forecast, by Form
- 7.2.5.3.3 Market size and forecast, by Distribution Channel
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.2.1 Europe Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
- 7.3.3 Europe Market size and forecast, by Form
- 7.3.4 Europe Market size and forecast, by Distribution Channel
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product
- 7.3.5.1.2 Market size and forecast, by Form
- 7.3.5.1.3 Market size and forecast, by Distribution Channel
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Product
- 7.3.5.2.2 Market size and forecast, by Form
- 7.3.5.2.3 Market size and forecast, by Distribution Channel
- 7.3.5.3 UK
- 7.3.5.3.1 Market size and forecast, by Product
- 7.3.5.3.2 Market size and forecast, by Form
- 7.3.5.3.3 Market size and forecast, by Distribution Channel
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Product
- 7.3.5.4.2 Market size and forecast, by Form
- 7.3.5.4.3 Market size and forecast, by Distribution Channel
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Product
- 7.3.5.5.2 Market size and forecast, by Form
- 7.3.5.5.3 Market size and forecast, by Distribution Channel
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Product
- 7.3.5.6.2 Market size and forecast, by Form
- 7.3.5.6.3 Market size and forecast, by Distribution Channel
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.2.1 Asia-Pacific Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Form
- 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Product
- 7.4.5.1.2 Market size and forecast, by Form
- 7.4.5.1.3 Market size and forecast, by Distribution Channel
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Product
- 7.4.5.2.2 Market size and forecast, by Form
- 7.4.5.2.3 Market size and forecast, by Distribution Channel
- 7.4.5.3 Australia
- 7.4.5.3.1 Market size and forecast, by Product
- 7.4.5.3.2 Market size and forecast, by Form
- 7.4.5.3.3 Market size and forecast, by Distribution Channel
- 7.4.5.4 India
- 7.4.5.4.1 Market size and forecast, by Product
- 7.4.5.4.2 Market size and forecast, by Form
- 7.4.5.4.3 Market size and forecast, by Distribution Channel
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Product
- 7.4.5.5.2 Market size and forecast, by Form
- 7.4.5.5.3 Market size and forecast, by Distribution Channel
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Product
- 7.4.5.6.2 Market size and forecast, by Form
- 7.4.5.6.3 Market size and forecast, by Distribution Channel
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.2.1 LAMEA Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
- 7.5.3 LAMEA Market size and forecast, by Form
- 7.5.4 LAMEA Market size and forecast, by Distribution Channel
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Product
- 7.5.5.1.2 Market size and forecast, by Form
- 7.5.5.1.3 Market size and forecast, by Distribution Channel
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Product
- 7.5.5.2.2 Market size and forecast, by Form
- 7.5.5.2.3 Market size and forecast, by Distribution Channel
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Product
- 7.5.5.3.2 Market size and forecast, by Form
- 7.5.5.3.3 Market size and forecast, by Distribution Channel
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Product
- 7.5.5.4.2 Market size and forecast, by Form
- 7.5.5.4.3 Market size and forecast, by Distribution Channel
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 British American Tobacco Plc
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 22nd Century group Inc.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Cipla Ltd.
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Dr. Reddy’s Laboratories Ltd.
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 GlaxoSmithKline Plc.
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Imperial Brands Plc.
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Johnson and Johnson Inc
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Njoy Company
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Perrigo Company Plc.
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Pfizer Inc.
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 Zydus Cadila, Inc.
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 Rusan Pharma Ltd
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 2. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE REPLACEMENT THERAPY PRODUCTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR NICOTINE REPLACEMENT THERAPY PRODUCTS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. GLOBAL NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 5. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE LOZENGES, BY REGION, 2021-2031 ($MILLION)
- TABLE 6. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE GUMS, BY REGION, 2021-2031 ($MILLION)
- TABLE 7. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE SPRAYS, BY REGION, 2021-2031 ($MILLION)
- TABLE 8. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE INHALERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 9. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR DRUG THERAPY, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR DRUG THERAPY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR E-CIGARETTES, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR E-CIGARETTES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 13. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 14. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR GUM, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR GUM, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 16. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR INHALER, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR INHALER, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 18. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR TABLET, BY REGION, 2021-2031 ($MILLION)
- TABLE 19. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR TABLET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 20. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 21. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 22. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 23. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 24. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 25. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR ONLINE PROVIDER, BY REGION, 2021-2031 ($MILLION)
- TABLE 26. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR ONLINE PROVIDER, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 27. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 28. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 29. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 30. NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 31. NORTH AMERICA NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 32. NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 33. NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 34. NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 35. U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 36. U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 37. U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 38. CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 39. CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 40. CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 41. MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 42. MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 43. MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 44. EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 45. EUROPE NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 46. EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 47. EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 48. EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 49. GERMANY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 50. GERMANY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 51. GERMANY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 52. FRANCE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 53. FRANCE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 54. FRANCE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 55. UK SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 56. UK SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 57. UK SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 58. ITALY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 59. ITALY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 60. ITALY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 61. SPAIN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 62. SPAIN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 63. SPAIN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 64. REST OF EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 65. REST OF EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 66. REST OF EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 67. ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 68. ASIA-PACIFIC NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 69. ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 70. ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 71. ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 72. JAPAN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 73. JAPAN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 74. JAPAN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 75. CHINA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 76. CHINA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 77. CHINA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 78. AUSTRALIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 79. AUSTRALIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 80. AUSTRALIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 81. INDIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 82. INDIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 83. INDIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 84. SOUTH KOREA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 85. SOUTH KOREA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 86. SOUTH KOREA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 87. REST OF ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 88. REST OF ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 89. REST OF ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 90. LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 91. LAMEA NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 92. LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 93. LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 94. LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 95. BRAZIL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 96. BRAZIL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 97. BRAZIL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 98. SAUDI ARABIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 99. SAUDI ARABIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 100. SAUDI ARABIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 101. SOUTH AFRICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 102. SOUTH AFRICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 103. SOUTH AFRICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 104. REST OF LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 105. REST OF LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
- TABLE 106. REST OF LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 107.BRITISH AMERICAN TOBACCO PLC: COMPANY SNAPSHOT
- TABLE 108.BRITISH AMERICAN TOBACCO PLC: OPERATING SEGMENTS
- TABLE 109.BRITISH AMERICAN TOBACCO PLC: PRODUCT PORTFOLIO
- TABLE 110.BRITISH AMERICAN TOBACCO PLC: NET SALES,
- TABLE 111.BRITISH AMERICAN TOBACCO PLC: KEY STRATERGIES
- TABLE 112.22ND CENTURY GROUP INC.: COMPANY SNAPSHOT
- TABLE 113.22ND CENTURY GROUP INC.: OPERATING SEGMENTS
- TABLE 114.22ND CENTURY GROUP INC.: PRODUCT PORTFOLIO
- TABLE 115.22ND CENTURY GROUP INC.: NET SALES,
- TABLE 116.22ND CENTURY GROUP INC.: KEY STRATERGIES
- TABLE 117.CIPLA LTD.: COMPANY SNAPSHOT
- TABLE 118.CIPLA LTD.: OPERATING SEGMENTS
- TABLE 119.CIPLA LTD.: PRODUCT PORTFOLIO
- TABLE 120.CIPLA LTD.: NET SALES,
- TABLE 121.CIPLA LTD.: KEY STRATERGIES
- TABLE 122.DR. REDDY’S LABORATORIES LTD.: COMPANY SNAPSHOT
- TABLE 123.DR. REDDY’S LABORATORIES LTD.: OPERATING SEGMENTS
- TABLE 124.DR. REDDY’S LABORATORIES LTD.: PRODUCT PORTFOLIO
- TABLE 125.DR. REDDY’S LABORATORIES LTD.: NET SALES,
- TABLE 126.DR. REDDY’S LABORATORIES LTD.: KEY STRATERGIES
- TABLE 127.GLAXOSMITHKLINE PLC.: COMPANY SNAPSHOT
- TABLE 128.GLAXOSMITHKLINE PLC.: OPERATING SEGMENTS
- TABLE 129.GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
- TABLE 130.GLAXOSMITHKLINE PLC.: NET SALES,
- TABLE 131.GLAXOSMITHKLINE PLC.: KEY STRATERGIES
- TABLE 132.IMPERIAL BRANDS PLC.: COMPANY SNAPSHOT
- TABLE 133.IMPERIAL BRANDS PLC.: OPERATING SEGMENTS
- TABLE 134.IMPERIAL BRANDS PLC.: PRODUCT PORTFOLIO
- TABLE 135.IMPERIAL BRANDS PLC.: NET SALES,
- TABLE 136.IMPERIAL BRANDS PLC.: KEY STRATERGIES
- TABLE 137.JOHNSON AND JOHNSON INC: COMPANY SNAPSHOT
- TABLE 138.JOHNSON AND JOHNSON INC: OPERATING SEGMENTS
- TABLE 139.JOHNSON AND JOHNSON INC: PRODUCT PORTFOLIO
- TABLE 140.JOHNSON AND JOHNSON INC: NET SALES,
- TABLE 141.JOHNSON AND JOHNSON INC: KEY STRATERGIES
- TABLE 142.NJOY COMPANY: COMPANY SNAPSHOT
- TABLE 143.NJOY COMPANY: OPERATING SEGMENTS
- TABLE 144.NJOY COMPANY: PRODUCT PORTFOLIO
- TABLE 145.NJOY COMPANY: NET SALES,
- TABLE 146.NJOY COMPANY: KEY STRATERGIES
- TABLE 147.PERRIGO COMPANY PLC.: COMPANY SNAPSHOT
- TABLE 148.PERRIGO COMPANY PLC.: OPERATING SEGMENTS
- TABLE 149.PERRIGO COMPANY PLC.: PRODUCT PORTFOLIO
- TABLE 150.PERRIGO COMPANY PLC.: NET SALES,
- TABLE 151.PERRIGO COMPANY PLC.: KEY STRATERGIES
- TABLE 152.PFIZER INC.: COMPANY SNAPSHOT
- TABLE 153.PFIZER INC.: OPERATING SEGMENTS
- TABLE 154.PFIZER INC.: PRODUCT PORTFOLIO
- TABLE 155.PFIZER INC.: NET SALES,
- TABLE 156.PFIZER INC.: KEY STRATERGIES
- TABLE 157.ZYDUS CADILA, INC.: COMPANY SNAPSHOT
- TABLE 158.ZYDUS CADILA, INC.: OPERATING SEGMENTS
- TABLE 159.ZYDUS CADILA, INC.: PRODUCT PORTFOLIO
- TABLE 160.ZYDUS CADILA, INC.: NET SALES,
- TABLE 161.ZYDUS CADILA, INC.: KEY STRATERGIES
- TABLE 162.RUSAN PHARMA LTD: COMPANY SNAPSHOT
- TABLE 163.RUSAN PHARMA LTD: OPERATING SEGMENTS
- TABLE 164.RUSAN PHARMA LTD: PRODUCT PORTFOLIO
- TABLE 165.RUSAN PHARMA LTD: NET SALES,
- TABLE 166.RUSAN PHARMA LTD: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET SEGMENTATION
- FIGURE 2.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031
- FIGURE 3.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,BY PRODUCT,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DRUG THERAPY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF E-CIGARETTES SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
- FIGURE 16.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,BY FORM,2021(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF GUM SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF INHALER SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF TABLET SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
- FIGURE 21.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,BY DISTRIBUTION CHANNEL,2021(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HOSPITAL PHARMACIES SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF ONLINE PROVIDER SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF DRUG STORES AND RETAIL PHARMACIES SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031(%)
- FIGURE 25.SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET BY REGION,2021
- FIGURE 26.U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
- FIGURE 27.CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
- FIGURE 28.MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
- FIGURE 29.GERMANY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
- FIGURE 30.FRANCE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
- FIGURE 31.UK SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
- FIGURE 32.ITALY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
- FIGURE 33.SPAIN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET,2021-2031($MILLION)
- FIGURE 34.REST OF EURO
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook